Masanori Noda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Masanori Noda has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Susumu Uchiyama
Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural Sciences, Okazaki, Japan
6 shared publications - Kiichi Fukui
Osaka University
3 shared publications Kotaro Hara
Grad. Sch. of Life and Environ. Sci., Kyoto Pref. Univ
2 shared publications- Masayuki Oda
Graduate School of Life and Environmental Sciences, Kyoto Prefectural University
2 shared publications - Shigeru Ueda
Asahi Kasei Pharma Co
2 shared publications - Ayaka Kanai
Department of Radiotheranostics, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan
1 shared publication
Latest Publications
- Open Access
Glycyrrhizin Derivatives Suppress Cancer Chemoresistance by Inhibiting Progesterone Receptor Membrane Component 1
Progesterone receptor membrane component 1 (PGRMC1) is highly expressed in various cancer cells and contributes to tumor progression. We have previously shown that PGRMC1 forms a unique heme-stacking functional dimer to enhance EGF receptor (EGFR) activity required for cancer proliferation and chemoresistance, and the dimer dissociates by carbon monoxide to attenuate its biological actions. Here, we determined that glycyrrhizin (GL), which is conventionally used to ameliorate inflammation, specifically binds to heme-dimerized PGRMC1. Binding analyses using isothermal titration calorimetry revealed that some GL derivatives, including its glucoside-derivative (GlucoGL), bind to PGRMC1 potently, whereas its aglycone, glycyrrhetinic acid (GA), does not bind. GL and GlucoGL inhibit the interaction between PGRMC1 and EGFR, thereby suppressing EGFR-mediated signaling required for cancer progression. GL and GlucoGL significantly enhanced EGFR inhibitor erlotinib- or cisplatin (CDDP)-induced cell death in human colon cancer HCT116 cells. In addition, GL derivatives suppressed the intracellular uptake of low-density lipoprotein (LDL) by inhibiting the interaction between PGRMC1 and the LDL receptor (LDLR). Effects on other pathways cannot be excluded. Treatment with GlucoGL and CDDP significantly suppressed tumor growth following xenograft transplantation in mice. Collectively, this study indicates that GL derivatives are novel inhibitors of PGRMC1 that suppress cancer progression, and our findings provide new insights for cancer treatment.
Open AccessGlycyrrhizin Derivatives Suppress Cancer Chemoresistance by Inhibiting Progesterone Receptor Membrane Component 1
Progesterone receptor membrane component 1 (PGRMC1) is highly expressed in various cancer cells and contributes to tumor progression. We have previously shown that PGRMC1 forms a unique heme-stacking functional dimer to enhance EGF receptor (EGFR) activity required for cancer proliferation and chemoresistance, and the dimer dissociates by carbon monoxide to attenuate its biological actions. Here, we determined that glycyrrhizin (GL), which is conventionally used to ameliorate inflammation, specifically binds to heme-dimerized PGRMC1. Binding analyses using isothermal titration calorimetry revealed that some GL derivatives, including its glucoside-derivative (GlucoGL), bind to PGRMC1 potently, whereas its aglycone, glycyrrhetinic acid (GA), does not bind. GL and GlucoGL inhibit the interaction between PGRMC1 and EGFR, thereby suppressing EGFR-mediated signaling required for cancer progression. GL and GlucoGL significantly enhanced EGFR inhibitor erlotinib- or cisplatin (CDDP)-induced cell death in human colon cancer HCT116 cells. In addition, GL derivatives suppressed the intracellular uptake of low-density lipoprotein (LDL) by inhibiting the interaction between PGRMC1 and the LDL receptor (LDLR). Effects on other pathways cannot be excluded. Treatment with GlucoGL and CDDP significantly suppressed tumor growth following xenograft transplantation in mice. Collectively, this study indicates that GL derivatives are novel inhibitors of PGRMC1 that suppress cancer progression, and our findings provide new insights for cancer treatment.
- Open Access
NMR Detection of Semi-Specific Antibody Interactions in Serum Environments
Although antibody functions are executed in heterogeneous blood streams characterized by molecular crowding and promiscuous intermolecular interaction, detailed structural characterizations of antibody interactions have thus far been performed under homogeneous in vitro conditions. NMR spectroscopy potentially has the ability to study protein structures in heterogeneous environments, assuming that the target protein can be labeled with NMR-active isotopes. Based on our successful development of isotope labeling of antibody glycoproteins, here we apply NMR spectroscopy to characterize antibody interactions in heterogeneous extracellular environments using mouse IgG-Fc as a test molecule. In human serum, many of the HSQC peaks originating from the Fc backbone exhibited attenuation in intensity of various magnitudes. Similar spectral changes were induced by the Fab fragment of polyclonal IgG isolated from the serum, but not by serum albumin, indicating that a subset of antibodies reactive with mouse IgG-Fc exists in human serum without preimmunization. The metaepitopes recognized by serum polyclonal IgG cover the entire molecular surface of Fc, including the binding sites to Fc receptors and C1q. In-serum NMR observation will offer useful tools for the detailed characterization of biopharamaceuticals, including therapeutic antibodies in physiologically relevant heterogeneous environments, also giving deeper insight into molecular recognition by polyclonal antibodies in the immune system.
Open AccessNMR Detection of Semi-Specific Antibody Interactions in Serum Environments
Although antibody functions are executed in heterogeneous blood streams characterized by molecular crowding and promiscuous intermolecular interaction, detailed structural characterizations of antibody interactions have thus far been performed under homogeneous in vitro conditions. NMR spectroscopy potentially has the ability to study protein structures in heterogeneous environments, assuming that the target protein can be labeled with NMR-active isotopes. Based on our successful development of isotope labeling of antibody glycoproteins, here we apply NMR spectroscopy to characterize antibody interactions in heterogeneous extracellular environments using mouse IgG-Fc as a test molecule. In human serum, many of the HSQC peaks originating from the Fc backbone exhibited attenuation in intensity of various magnitudes. Similar spectral changes were induced by the Fab fragment of polyclonal IgG isolated from the serum, but not by serum albumin, indicating that a subset of antibodies reactive with mouse IgG-Fc exists in human serum without preimmunization. The metaepitopes recognized by serum polyclonal IgG cover the entire molecular surface of Fc, including the binding sites to Fc receptors and C1q. In-serum NMR observation will offer useful tools for the detailed characterization of biopharamaceuticals, including therapeutic antibodies in physiologically relevant heterogeneous environments, also giving deeper insight into molecular recognition by polyclonal antibodies in the immune system.
- 1 January 2015
- Published by Biophysical Society of Japan in Seibutsu Butsuri
- Vol. 55 (5) , 270-273
Analysis of Higher Order Structures of Proteins by Mass Spectrometry
- 1 January 2015
- Published by Biophysical Society of Japan in Seibutsu Butsuri
- Vol. 55 (5) , 270-273
Analysis of Higher Order Structures of Proteins by Mass Spectrometry
- 1 January 2011
- Published by Biophysical Society of Japan in Seibutsu Butsuri
- Vol. 51 (supplement) , S80-S81
2D1536 Correlation between dimerization ability of 3α-hydroxysteroid dehydrogenase and its enzymatic function(Protein: Structure & Function 1,The 48th Annual Meeting of the Biophysical Society of Japan)
- 1 January 2011
- Published by Biophysical Society of Japan in Seibutsu Butsuri
- Vol. 51 (supplement) , S80-S81
2D1536 Correlation between dimerization ability of 3α-hydroxysteroid dehydrogenase and its enzymatic function(Protein: Structure & Function 1,The 48th Annual Meeting of the Biophysical Society of Japan)
- 1 January 2010
- Published by Biophysical Society of Japan in Seibutsu Butsuri
- Vol. 50 (supplement) , S25
1P035 Roles of Arg251 and Phe255 at the dimer interface of 3α-hydroxysteroid dehydrogenase(Protein:Structure & Function,The 48th Annual Meeting of the Biophysical Society of Japan)
- 1 January 2010
- Published by Biophysical Society of Japan in Seibutsu Butsuri
- Vol. 50 (supplement) , S25
1P035 Roles of Arg251 and Phe255 at the dimer interface of 3α-hydroxysteroid dehydrogenase(Protein:Structure & Function,The 48th Annual Meeting of the Biophysical Society of Japan)